ASK REDCHAT ANYTHING ABOUT SOLID BIOSCIENCES INC.
Solid Biosciences Inc. (NASDAQ: SLDB)
Listen to this Section
$7.36
+0.5120
(
+7.47% )
212.9K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| SGT-003DetailsGenetic disorder, Duchenne muscular dystrophy |
Phase 1/2 |
| SGT-001 (Microdystrophin Gene Transfer)DetailsGenetic disorder, Muscle weakness, Muscle degeneration |
Failed |
Market Data
| Open |
$7.36 |
| Previous Close |
$6.85 |
| Volume |
212.9K |
| Market Cap |
$674.38M |
| Day Range |
$6.68 - $7.41 |
| 52 Week Range |
$3.41 - $8.87 |
| Shares Outstanding |
98.45M |
| Change % |
+7.47% |
| Net Change |
▲ 0.5120 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| IPO Year | 2018 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
1,297,008.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-04-05 |
Sale |
-3256.00 |
SMITH IAN F |
| 2024-02-16 |
Sale |
-117500.00 |
Howton David T |
| 2024-02-16 |
Sale |
-85000.00 |
Tan Kevin |
| 2024-02-16 |
Sale |
-90000.00 |
Marlowe Jennifer |
| 2024-02-16 |
Sale |
-57500.00 |
Herzich Paul |
| 2024-02-16 |
Sale |
-19444.00 |
Ganot Ilan |
| 2024-02-16 |
Sale |
-240250.00 |
Cumbo Alexander |
| 2024-02-16 |
Sale |
-65000.00 |
Hanrahan Jessie |
| 2024-02-16 |
Sale |
-87500.00 |
Brooks Gabriel |
| 2024-01-30 |
Sale |
-388.00 |
Ganot Ilan |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 4 |
Insider transactions |
1 |
Nov 13, 2025 |
| 10-q |
Quarterly Reports |
68 |
Nov 03, 2025 |
| 8-k |
8K-related |
64 |
Nov 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 21, 2025 |
| 4 |
Insider transactions |
1 |
Oct 07, 2025 |
| 4 |
Insider transactions |
1 |
Aug 18, 2025 |
| 4 |
Insider transactions |
1 |
Aug 18, 2025 |
| 4 |
Insider transactions |
1 |
Aug 18, 2025 |
| 4 |
Insider transactions |
1 |
Aug 18, 2025 |
| 4 |
Insider transactions |
1 |
Aug 18, 2025 |